Married after a 5-minute video call, sought divorce 9 days later: Chinese man's story sparks debateA Chinese man, pressured by family, married a woman after a brief video call and three days of acquaintance. Nine days later, he sought a d...
Tribal girl watched her father heal the sick; that inherited wisdom made her the ‘Queen of Herbs’, helping over 300,000 patients battle deadly diseasesYanung Jamoh Lego, popularly known as the 'Adi Queen of Herbs', is a traditional healer from Arunachal Pradesh who has spent more than thre...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCMarkets traded subdued with the India VIX correcting nearly 15% this week, though this hasn't significantly impacted benchmark index moveme...
Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
Ebola virus in India? Here's the latest update on the Bengaluru scare, symptoms and precautions explainedEbola virus in Bangalore: A woman returning from Uganda was quarantined in Bengaluru with Ebola-like symptoms. Her tests have come back neg...
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
Ebola outbreak declared emergency of international concern: What is it, how does it spread, and is there a vaccine?The World Health Organization has declared the Ebola outbreak in Democratic Republic of Congo and Uganda a global health emergency. The vir...
Who is Ashok Bahar? The 71-year-old who appeared for NEET to fulfil a promise to his mother, only for 2026 paper leak to change everythingNEET UG 2026 paper leak: Ashok Bahar, a 71-year-old from Uttar Pradesh, pursued his lifelong dream of becoming a doctor by appearing for th...
Zinc phosphide killed the family of four in Mumbai watermelon case: All about the toxic rat poison that can kill you in minutesA Mumbai family of four tragically died after consuming watermelon laced with rat poison, zinc phosphide. According to medical experts, zin...
After liver cancer, Dipika Kakar faces a new health crisis, says ‘I can’t do anything about it’ in husband Shoaib Ibrahim’s vlogTV actress Dipika Kakkar has been diagnosed with two dot-sized cysts and the health update was shared in her husband Shoaib Ibrahim’s vlog....
Researchers develop new approach to treat liver cancer with microrobotsResearchers in Canada have devised a groundbreaking method for treating liver cancer using magnet-guided microrobots within an MRI device. ...
Zydus, Lupin enter licensing pact to market drug to treat liver diseaseZydus launched the drug under the brand names Lipaglyn and Bilypsa and will continue to market them. Lupin will pay Zydus upfront licensing...